HIMS Hims & Hers Health
$14.60 -8.86%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-8.86%
YTD
-55.00%
P/E
26.66
P/B
13.66
ROE
-45.8%
Div yield
—
Beta
2.62
Market cap
$3.4B
RSI (14)
25
Next earnings
Feb 22, 2027
Same sector · Health Care
Compare HIMS with NVO and JNJ →Follow HIMS in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$15.51
Close
$14.60
Day high
$15.96
Day low
$14.51
Volume
16.1M
Latest headlines
Hims & Hers Launches Peptides+ to Expand Personalized Health Care
Yahoo Finance · Nov 20
Hims & Hers Health (HIMS) Launches Peptides+ Longevity Platform Across The U.S.
Yahoo Finance · Nov 20
Hims & Hers Health (HIMS) Stock Looks Discounted Even As Risks Stay In Focus
Yahoo Finance · Nov 20
The Trump Administration Gave Hims & Hers a Big Boost, and HIMS Stock Is Cashing In
Yahoo Finance · Nov 19
Could Hims & Hers Stock Fall 63% Again?
Yahoo Finance · Nov 19
Hims Is Getting into Peptides
Yahoo Finance · Nov 18
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Nov 9, 2026 View → 8-K Nov 9, 2026 View → 8-K Nov 9, 2026 View → 8-K Oct 7, 2026 View → 10-Q Aug 10, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell HIMS. Try it in the Lab to size a position and see the risk.